- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Androgen deprivation therapy
Total 53051 results
-
Yale UniversityNational Cancer Institute (NCI)RecruitingStage IV Prostate Adenocarcinoma AJCC v7United States, Taiwan, Korea, Republic of, Australia, China, Japan
-
National Cancer Institute (NCI)Recruiting
-
Sun Yat-sen UniversityRecruitingProstate Cancer MetastaticChina
-
McMaster UniversityCanadian Cancer Society (CCS); Prostate Cancer CanadaRecruitingCardiovascular Disease | Prostate CancerUnited States, Canada, Australia, Brazil, Israel, Turkey, Colombia
-
University of MiamiBankhead-Coley Florida Biomedical Research ProgramRecruitingProstate CancerUnited States
-
Sir Mortimer B. Davis - Jewish General HospitalRecruitingProstate CancerCanada
-
Olof AkreRecruitingProstatic NeoplasmsDenmark, Norway, Finland, Sweden
-
Advocate Health CareRecruitingProstate AdenocarcinomaUnited States
-
M.D. Anderson Cancer CenterBristol-Myers Squibb; Stand Up To Cancer; High Impact Clinical Research Support...Completed
-
Aragon Pharmaceuticals, Inc.Active, not recruitingProstate CancerUnited States, France, Poland, Ukraine, United Kingdom, China, Spain, Argentina, Israel, Mexico, Romania, Turkey, Korea, Republic of, Japan, Sweden, Canada, Russian Federation, Brazil, Germany, Hungary, Czechia, Australia
-
Janssen Pharmaceutical K.K.Active, not recruiting
-
Janssen Research & Development, LLCActive, not recruiting
-
Astellas Pharma Global Development, Inc.Medivation LLC, a wholly owned subsidiary of Pfizer Inc.Active, not recruitingMetastatic Hormone Sensitive Prostate CancerKorea, Republic of, Japan, United States, Argentina, Australia, Belgium, Canada, Chile, Denmark, Finland, France, Germany, Israel, Italy, Netherlands, New Zealand, Poland, Romania, Russian Federation, Slovakia, Spain, Sweden, Taiwan, United...
-
Janssen Research & Development, LLCActive, not recruitingProstatic NeoplasmsUnited States, Italy, Czechia, Israel, Japan, Taiwan, Korea, Republic of, United Kingdom, France, Spain, Germany, Australia, Canada, Brazil, Netherlands, Russian Federation, Argentina, Poland
-
BayerOrion Corporation, Orion PharmaActive, not recruitingDarolutamide in Addition to ADT Versus ADT in Metastatic Hormone-sensitive Prostate Cancer (ARANOTE)Prostatic NeoplasmsChina, Russian Federation, Taiwan, Latvia, India, Australia, Brazil, Canada, Chile, Lithuania, New Zealand, Peru, South Africa, Spain, Ukraine
-
University of ChicagoJanssen, LPSuspendedProstate CancerUnited States
-
University of Kansas Medical CenterOncology Nursing SocietyCompletedFatigue | Cognitive Impairment | Sleep Disturbance | Prostate CancerUnited States
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingProstate CancerUnited States
-
Andrew McDonaldNational Cancer Institute (NCI)Active, not recruitingProstate AdenocarcinomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingProstate Cancer | Neoplasms of Prostate | Cancer Of Prostate | Prostate Neoplasms | Prostatic CancerUnited States
-
Sunnybrook Health Sciences CentreActive, not recruiting
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingMetastatic Malignant Neoplasm in Lymph Node | Prostate Ductal Adenocarcinoma | Stage III Prostate Adenocarcinoma AJCC v7 | Stage IV Prostate Adenocarcinoma AJCC v7United States
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI); NRG Oncology; Cancer and Leukemia Group BActive, not recruitingProstate CancerUnited States, Canada, China, Israel
-
University of FloridaActive, not recruitingAdenocarcinoma of the ProstateUnited States
-
University of Colorado, DenverActive, not recruitingRecurrent Prostate Cancer | Stage III Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate CancerUnited States
-
University of Wisconsin, MadisonUnited States Department of Defense; Prostate Cancer FoundationCompletedProstate CancerUnited States
-
Medical University of South CarolinaActive, not recruiting
-
BayerActive, not recruitingMetastatic Hormone-sensitive Prostate CancerUnited States
-
AstraZenecaActive, not recruitingHormone-Sensitive Prostate CancerUnited States, Belgium, Spain, Canada, Poland, Argentina, India, Taiwan, Thailand, Vietnam, Turkey, Russian Federation, France, Germany, Korea, Republic of, Brazil, Mexico, Peru, Philippines, China, United Kingdom, Hong Kong, Israel, ... and more
-
Novartis PharmaceuticalsAlliance Foundation Trials, LLC.; RTOG Foundation, Inc.Active, not recruitingProstatic NeoplasmsUnited States, China, Canada, Spain, United Kingdom, Belgium, Japan, Taiwan, Germany, Singapore, Austria, Netherlands, Korea, Republic of, France, Switzerland, Denmark, Sweden, Poland, Czechia
-
Xiao X. Wei, MDBristol-Myers SquibbActive, not recruitingProstate Adenocarcinoma | Hormone Sensitive Prostate Cancer | Metastasis Prostate AdenocarcinomaUnited States
-
BayerOrion Corporation, Orion PharmaCompletedMetastatic Hormone-sensitive Prostate CancerBelgium, France, Sweden, China, Canada, United States, Spain, Taiwan, Japan, Finland, Korea, Republic of, Australia, Brazil, Czechia, Israel, Italy, Netherlands, Russian Federation, Bulgaria, United Kingdom, Germany, Poland, Mexico
-
Medical College of WisconsinActive, not recruiting
-
UNICANCERSanofiActive, not recruitingAdenocarcinoma of Prostate | Progression of Prostate CancerFrance
-
European Organisation for Research and Treatment...BayerActive, not recruitingProstate CancerBelgium, Spain, France, Italy
-
European Organisation for Research and Treatment...Active, not recruitingProstate CancerGermany, Spain, France, Belgium, United Kingdom, Switzerland, Italy, Denmark
-
Merck Sharp & Dohme LLCActive, not recruitingMetastatic Hormone-Sensitive Prostate CancerChina
-
Astellas Pharma IncCompletedMetastatic Castration Resistant Prostate CancerIndia
-
University of Colorado, DenverCancer League of ColoradoActive, not recruitingProstate Cancer | Castration-Resistant Prostate CancerUnited States
-
Canadian Urologic Oncology GroupBritish Columbia Cancer Agency; Prostate Cancer Canada; BC Cancer FoundationTerminatedMetabolic Syndrome | Prostate CancerCanada
-
Andrew J. Armstrong, MDCompleted
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)Active, not recruitingMetastatic Hormone-sensitive Prostate CancerUnited States
-
University of Alabama at BirminghamActive, not recruitingProstate CancerUnited States
-
Universidad Central de VenezuelaCompletedHemorrhoids | Defecation DisorderVenezuela
-
Memorial Sloan Kettering Cancer CenterFerring PharmaceuticalsActive, not recruitingProstate Cancer | Prostatic AdenocarcinomaUnited States
-
Praful Ravi, MB BCHir, MRCPEli Lilly and Company; BayerActive, not recruitingProstate Cancer | Metastatic Prostate Cancer | Non-metastatic Prostate CancerUnited States
-
OHSU Knight Cancer InstituteJanssen Scientific Affairs, LLC; Oregon Health and Science UniversityActive, not recruitingMetastatic Prostate Carcinoma | Stage IVB Prostate Cancer AJCC v8 | Castration-Sensitive Prostate CarcinomaUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteBristol-Myers SquibbActive, not recruitingProstate Cancer | Prostate DiseaseUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteActive, not recruitingProstate Cancer | Advanced Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate CancerUnited States
-
University of SydneyNational Health and Medical Research Council, Australia; European Organisation... and other collaboratorsActive, not recruitingProstatic NeoplasmsUnited States, Australia, United Kingdom, Spain, New Zealand, Ireland, Austria, Belgium, Slovenia